Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0032 | 1 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |